These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Pulkkinen JO; Klemi P; Martikainen P; Grénman R Anticancer Res; 1999; 19(1B):703-7. PubMed ID: 10216480 [TBL] [Abstract][Full Text] [Related]
63. Relationship between changes in prostate cancer cell proliferation, apoptotic index, and expression of apoptosis-related proteins by neoadjuvant hormonal therapy and duration of such treatment. Miyata Y; Kanda S; Sakai H; Hakariya T; Kanetake H Urology; 2005 Jun; 65(6):1238-43. PubMed ID: 15922418 [TBL] [Abstract][Full Text] [Related]
64. Bcl-2 immunohistochemical detection in prostate cancer. Sulik M; Guzińska-Ustymowicz K Rocz Akad Med Bialymst; 2002; 47():254-61. PubMed ID: 12533968 [TBL] [Abstract][Full Text] [Related]
65. Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients. Guo Y; Sigman DB; Borkowski A; Kyprianou N Prostate; 2000 Feb; 42(2):130-6. PubMed ID: 10617870 [TBL] [Abstract][Full Text] [Related]
66. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy. Abaza R; Diaz LK; Laskin WB; Pins MR J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199 [TBL] [Abstract][Full Text] [Related]
67. Potential role of apoptosis and apoptotic regulatory proteins in colorectal neoplasia: correlations with clinico-pathological parameters and survival. Tzouvala M; Lazaris AC; Papatheodoridis GV; Kouvidou C; Papathomas TG; Kavantzas N; Elemenoglou I; Karamanolis DG; Agapitos E Dig Dis Sci; 2008 Feb; 53(2):451-60. PubMed ID: 17562177 [TBL] [Abstract][Full Text] [Related]
68. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203 [TBL] [Abstract][Full Text] [Related]
69. Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. Merseburger AS; Kuczyk MA; Serth J; Bokemeyer C; Young DY; Sun L; Connelly RR; McLeod DG; Mostofi FK; Srivastava SK; Stenzl A; Moul JW; Sesterhenn IA Oncol Rep; 2003; 10(1):223-8. PubMed ID: 12469173 [TBL] [Abstract][Full Text] [Related]
70. Accurate prostate tumour detection with multiparametric magnetic resonance imaging: dependence on histological properties. Borren A; Groenendaal G; Moman MR; Boeken Kruger AE; van Diest PJ; van Vulpen M; Philippens ME; van der Heide UA Acta Oncol; 2014 Jan; 53(1):88-95. PubMed ID: 24041257 [TBL] [Abstract][Full Text] [Related]
71. Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones. Kirschenbaum A; Liu XH; Yao S; Narla G; Friedman SL; Martignetti JA; Levine AC Carcinogenesis; 2006 Feb; 27(2):216-24. PubMed ID: 16123118 [TBL] [Abstract][Full Text] [Related]
72. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery. Stapleton AM; Zbell P; Kattan MW; Yang G; Wheeler TM; Scardino PT; Thompson TC Cancer; 1998 Jan; 82(1):168-75. PubMed ID: 9428494 [TBL] [Abstract][Full Text] [Related]
73. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population. Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429 [TBL] [Abstract][Full Text] [Related]
74. Patterns of spread of adenocarcinoma in the prostate as related to cancer volume. McNeal JE; Haillot O Prostate; 2001 Sep; 49(1):48-57. PubMed ID: 11550210 [TBL] [Abstract][Full Text] [Related]
75. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin. Xing N; Qian J; Bostwick D; Bergstralh E; Young CY Prostate; 2001 Jun; 48(1):7-15. PubMed ID: 11391682 [TBL] [Abstract][Full Text] [Related]
76. Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma. Chen D; Zheng X; Kang D; Yan B; Liu X; Gao Y; Zhang K Med Princ Pract; 2012; 21(1):68-73. PubMed ID: 22024503 [TBL] [Abstract][Full Text] [Related]